Patient Registration and Treatment Allocation in Multicenter Clinical Trials Using a FAX-OCR System

Abstract:

This article describes the design and results of implementation of an automated patient registration and freatment allocation system (RETAS) used in multicenter clinical trials. RETAS was developed using a FAX-OCR system by which handwritten Japanese and English characters, as well as numericals and forms with check boxes, are sent from participating institutions by Fax, processed using an optical character reader, and then transmitted to a host computer at a statistical center. Based on the facsimile data, RETAS can automatically review eligibility, collect patient identification data and provide a randomized treatment allocation. RETAS permits uninterrupted, unattended operation at a statistical center, 24 hours a day, 7 days a week. Therefore, it drastically decreases the workload of personnel at the statistical center needed to support central telephone registration coverage. Consequently, staff members are free to focus on patient registration, treatment allocation, and follow-up of patients. The treatment allocation procedure in this system is based on Pocock and Simon’s minimization method combined with Zelen’s method for institution balancing. By this system it was possible to balance treatment numbers for each level of various prognostic factors over an entire trial and, at the same time, balance the allocation of treatments within an institution. The system currently supports the protocol of a clinical trial for Adjuvant Chemo-Endocrine Therapy for Breast Cancer in West Japan.

Keywords:

Patient Registration - Treatment Allocation - FAX-OCR System - Clinical Trial

• REFERENCES

• 1 Krischer JP, Hurley C, Pillalamarri M. et al. An automated patient registration and treatment randomization system for multicenter clinical trials. Controlled Clin Trials 1991; 12: 367-77.
• 2 Lange N, Maclntyre J. A computerized patient registration and treatment randomization system for multi-institutional clinical trials. Controlled Clin Trials 1985; 06: 38-50.
• 3 Akazawa K, Odaka T, Sakamoto M. et al. A random allocation system with the minimization method for multi-institutional clinical trials. J Med Systems 1991; 15: 311-9.
• 4 Pocock SJ. Allocation of patients to treatment in clinical trials. Biometrics 1979; 35: 183-97.
• 5 Zelen M. The randomization and stratification of patients to clinical trials. J Chron Dis 1974; 27: 365-75.
• 6 Toi M, Hattori T, Akagi M. et al. Randomized adjuvant trial to evaluate the addition of Tamoxifen and PSK to chemotherapy in patients with primary breast cancer. Cancer 1992; 70: 2475-83.
• 7 Akazawa K, Nakamura T, Moriguchi S, Shimada M, Nose Y. Simulation program for estimating statistical power of Cox’s proportional hazards model assuming no specific distribution for the survival time. Comput Meth Progr Biomed 1991; 35: 203-12.
• 8 Johnson ME, Tolley HD, Bryson MC, Goldman AS. Covariate analysis of survival data: A small-sample study of Cox’s model. Biometrics 1982; 38: 685-98.